SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-17-108745
Filing Date
2017-04-03
Accepted
2017-04-03 17:21:05
Documents
4
Period of Report
2017-05-25

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d302409dpre14a.htm PRE 14A 531312
2 GRAPHIC g302409g19o28.jpg GRAPHIC 7942
3 GRAPHIC g302409g34x21.jpg GRAPHIC 1957
4 GRAPHIC g302409g83j83.jpg GRAPHIC 3177
  Complete submission text file 0001193125-17-108745.txt   551031
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33057 | Film No.: 17735273
SIC: 2834 Pharmaceutical Preparations